Efforts Toward Consensus Variant Interpretation by Commercial Laboratories

J Clin Oncol. 2017 Apr 10;35(11):1261-1262. doi: 10.1200/JCO.2016.71.2505. Epub 2017 Jan 30.

Authors

Jill S Dolinsky¹, Kathleen S Hruska¹, Tina Pesaran¹, Marcy E Richardson¹, Rachel T Klein¹, Benjamin D Solomon¹, Chia-Ling Gau¹

Affiliation

¹ Jill S. Dolinsky, Ambry Genetics, Aliso Viejo, CA; Kathleen S. Hruska, GeneDx, Gaithersburg, MD; Tina Pesaran and Marcy E. Richardson, Ambry Genetics, Aliso Viejo, CA; Rachel T. Klein and Benjamin D. Solomon, GeneDx, Gaithersburg, MD; and Chia-Ling Gau, Ambry Genetics, Aliso Viejo, CA.

PMID: 28135139
DOI: 10.1200/JCO.2016.71.2505

No abstract available

Publication types

Letter
Comment

MeSH terms

Consensus
Genetic Testing
Humans
Laboratories*
Neoplasms / genetics*
Prospective Studies
Registries